Follow The Filings

KRMD KORU Medical Systems

KORU Medical Systems earnings company data as of 4:47 AM ET 10/22

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 11 Nov EPS 0.00 — —
Rev — — —

Insider trades

Open-market buys and sales by KRMD's executives, directors and 10% owners in the last 12 months, from their Form 4s

All KRMD insider trades
  • $215K bought by 5 insiders
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. Adam R Kalbermatten Chief Commercial Officer
    Buy
    $101K 32,000 shares at $3.16 +8.8% to stake
    Traded Sep 8 Filed Sep 9
    ↗
  2. Adam R Kalbermatten President-Chief Commercial Off
    Buy
    $49K 12,500 shares at $3.94
    Traded Jun 11 Filed Jun 15
    ↗
  3. Eric Schiller Chief Technology Officer
    Buy
    $20K 5,000 shares at $3.91 New stake
    Traded May 18 Filed May 20
    ↗
  4. Linda M Tharby CEO
    Buy
    $4,669 1,191 shares at $3.92 +0.2% to stake
    Traded May 15 Filed May 20
    ↗
  5. Christopher Pazdan COO
    Buy
    $19K 5,000 shares at $3.88 +1.7% to stake
    Traded May 14 Filed May 18
    ↗
  6. Thomas Edward Adams CFO
    Buy
    $21K 5,500 shares at $3.86 +1.8% to stake
    Traded May 14 Filed May 18
    ↗

Also filed in the last 12 months, not counted as buying or selling: 25 stock grants, 7 share withholdings for taxes, 7 option exercises, 5 other transactions, and 1 gift.

SEC filings

Recent issuer filings from EDGAR, 11 shown.

Filed Form Detail Links
8-K 5.03,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q FORM 10-Q QUARTERLY REPORT FOR 06-30-2026 Filing Doc
SCHEDULE 13G — Filing Doc
8-K 1.01,9.01 Filing Doc
8-K 5.07 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q FORM 10-Q QUARTERLY REPORT FOR 03-31-2026 Filing Doc
SCHEDULE 13G/A — Filing Doc
DEF 14A SCHEDULE 14A DEFINITIVE PROXY STATEMENT Filing Doc
8-K 1.01,2.03,9.01 Filing Doc

Source: SEC EDGAR submissions, updated 6 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.